Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Teijeira

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Cancer Immunology Research|October 3, 2019
Metabolic Consequences of T-cell Costimulation in Anticancer ImmunityAlvaro Teijeira, Saray Garasa, Inaki Etxeberria, et al.
Frontiers in Immunology|April 11, 2019
Dendritic Cells and T Cells Interact Within Murine Afferent Lymphatic CapillariesMorgan Campbell Hunter, Alvaro Teijeira, Riccardo Montecchi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 12, 2010
Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatmentEva Martínez-García, Marta Irigoyen, Oscar González-Moreno, et al.
Oncoimmunology|June 23, 2017
Cellular immunotherapies for cancerPedro Berraondo, Sara Labiano, Luna Minute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer ImmunotherapyIrene Olivera, Carlos Luri-Rey, Alvaro Teijeira, et al.
ACS Nano|August 5, 2017
Microinjection for the ex Vivo Modification of Cells with Artificial OrganellesPeter Tiefenboeck, Jong Ah Kim, Ferdinand Trunk, et al.
Journal for Immunotherapy of Cancer|February 28, 2020
Repurposing infectious disease vaccines for intratumoral immunotherapyIgnacio Melero, Maria Gato, Tala Shekarian, et al.
Immunological Reviews|October 12, 2023
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-primingCarlos Luri-Rey, Gabriel Gomis, Javier Glez-Vaz, et al.
Cell Reports|February 16, 2016
Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic VesselsErica Russo, Alvaro Teijeira, Kari Vaahtomeri, et al.
International Journal of Cancer|October 2, 2012
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLCErik Oliemuller, Rafael Peláez, Saray Garasa, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Cancer Immunology Research|October 3, 2019
Metabolic Consequences of T-cell Costimulation in Anticancer ImmunityAlvaro Teijeira, Saray Garasa, Inaki Etxeberria, et al.
Frontiers in Immunology|April 11, 2019
Dendritic Cells and T Cells Interact Within Murine Afferent Lymphatic CapillariesMorgan Campbell Hunter, Alvaro Teijeira, Riccardo Montecchi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 12, 2010
Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatmentEva Martínez-García, Marta Irigoyen, Oscar González-Moreno, et al.
Oncoimmunology|June 23, 2017
Cellular immunotherapies for cancerPedro Berraondo, Sara Labiano, Luna Minute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer ImmunotherapyIrene Olivera, Carlos Luri-Rey, Alvaro Teijeira, et al.
ACS Nano|August 5, 2017
Microinjection for the ex Vivo Modification of Cells with Artificial OrganellesPeter Tiefenboeck, Jong Ah Kim, Ferdinand Trunk, et al.
Journal for Immunotherapy of Cancer|February 28, 2020
Repurposing infectious disease vaccines for intratumoral immunotherapyIgnacio Melero, Maria Gato, Tala Shekarian, et al.
Immunological Reviews|October 12, 2023
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-primingCarlos Luri-Rey, Gabriel Gomis, Javier Glez-Vaz, et al.
Cell Reports|February 16, 2016
Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic VesselsErica Russo, Alvaro Teijeira, Kari Vaahtomeri, et al.
International Journal of Cancer|October 2, 2012
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLCErik Oliemuller, Rafael Peláez, Saray Garasa, et al.
Pageof 7